An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya

Principle Instigator
Prof. Walter Jaoko
Abstract

Primary Objective:  To measure cervical mucosal immune activation after VZV vaccination in the context of VZV-effector responses